M. M. D. F. John H. Kelly, MD Mph Faclm Facpm DipABLM Liana Lianov, MD Mba Mph Faclm DipABLM Sley Dexter Shurney, MD DipIBLM Tanigawa Guimarães, M. M. D. F. . Mechelle Palma, Faclm Caldwell Esselstyn MD, MD Fabpmr Scott Stoll, MD Faclm DipABLM Padmaja Patel, MD DrPH PT RD Faclm Brenda Rea, MD Facc Faclm Koushik Reddy, D. George, Mary M Guthrie, M. L. C. F. F. M. C. Reiss, P. Karlsen
2004.9.1Spine Deformity
tlooto सारांश
A consensus statement on interference with the IL-6 pathway based on evidence and expert opinion aimed at supporting clinicians and informing patients, administrators and payers on opportunities and limitations of IL-6 pathway inhibition.
सारांश
: Objective: The objective of this expert consensus process was to de fi ne performance measures that can be used to document remission or long-term progress following lifestyle medicine (LM) treatment. Methods: Expert panel members with experience in intensive, therapeutic lifestyle change (ITLC) developed a list of performance measures for key disease states, using an established process for developing consensus statements adapted for the topic. Proposed performance measures were assessed for consensus using a modi fi ed Delphi process. Results: After a series of meetings and an iterative Delphi process of voting and revision, a fi nal set of 32 performance measures achieved consensus. These were grouped in 10 domains of diseases, conditions, or risk factors, including (1) Cardiac function,
साइटेशन फॉर्मेट
KELLY, M. M. D. F. John H., et al. Consensus statement. Spine Deformity, 2004, 3: 107.